226 related articles for article (PubMed ID: 26355427)
1. Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management.
Kakati B; Seetharam A
J Clin Transl Hepatol; 2014 Sep; 2(3):189-96. PubMed ID: 26355427
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C infection before and after liver transplantation.
Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
[TBL] [Abstract][Full Text] [Related]
3. Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.
Punzalan CS; Barry C; Zacharias I; Rodrigues J; Mehta S; Bozorgzadeh A; Barnard GF
Clin Transplant; 2015 Dec; 29(12):1105-11. PubMed ID: 26358816
[TBL] [Abstract][Full Text] [Related]
4. Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation.
Crittenden NE; Buchanan LA; Pinkston CM; Cave B; Barve A; Marsano L; McClain CJ; Jones CM; Marvin MR; Davis EG; Kuns-Adkins CB; Gedaly R; Brock G; Shah MB; Rosenau J; Cave MC
Liver Transpl; 2016 May; 22(5):635-43. PubMed ID: 26915588
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of recurrent hepatitis C infection after liver transplantation].
Filipec Kanizaj T; Colić Cvrlje V; Mrzljak A; Ostojić R
Acta Med Croatica; 2009 Dec; 63(5):451-7. PubMed ID: 20198907
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1.
Lutchman G; Nguyen NH; Chang CY; Ahmed A; Daugherty T; Garcia G; Kumari R; Gupta S; Doshi D; Nguyen MH
Aliment Pharmacol Ther; 2016 Oct; 44(7):738-46. PubMed ID: 27506182
[TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.
Willemse SB; Baak LC; Kuiken SD; van der Sluys Veer A; Lettinga KD; van der Meer JT; Depla AC; Tuynman H; van Nieuwkerk CM; Schinkel CJ; Kwa D; Reesink HW; van der Valk M
J Viral Hepat; 2016 Dec; 23(12):950-954. PubMed ID: 27405785
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.
Sanchez Antolin G; Testillano M; Pascasio JM; Narvaez Rodriguez I; Prieto M; Otero A; Herrero JI; Londoño M; Fernandez Vazquez I; Castells L;
Transplant Proc; 2016 Nov; 48(9):3013-3016. PubMed ID: 27932134
[TBL] [Abstract][Full Text] [Related]
10. Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients.
Saxena V; Terrault N
Clin Liver Dis; 2015 Nov; 19(4):669-88, vi. PubMed ID: 26466655
[TBL] [Abstract][Full Text] [Related]
11. INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse - a Swedish real life experience.
Castedal M; Segenmark M; Cederberg S; Skoglund C; Weiland O
Scand J Gastroenterol; 2017 May; 52(5):585-588. PubMed ID: 28270038
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for chronic hepatitis C prior to and following liver transplantation.
Perumpail RB; Hahambis TA; Aggarwal A; Younossi ZM; Ahmed A
World J Hepatol; 2016 Jan; 8(1):69-73. PubMed ID: 26783422
[TBL] [Abstract][Full Text] [Related]
13. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.
Cholongitas E; Pipili C; Papatheodoridis G
World J Gastroenterol; 2015 Aug; 21(32):9526-33. PubMed ID: 26327760
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of recurrent HCV infection after liver transplantation].
Ostojić R
Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
[TBL] [Abstract][Full Text] [Related]
15. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.
Wali M; Harrison RF; Gow PJ; Mutimer D
Gut; 2002 Aug; 51(2):248-52. PubMed ID: 12117889
[TBL] [Abstract][Full Text] [Related]
16. Management of recurrent hepatitis C following liver transplantation.
Gonzalez SA
Gastroenterol Hepatol (N Y); 2010 Oct; 6(10):637-45. PubMed ID: 21103443
[TBL] [Abstract][Full Text] [Related]
17. Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.
Martini S; Sacco M; Strona S; Arese D; Tandoi F; Dell Olio D; Stradella D; Cocchis D; Mirabella S; Rizza G; Magistroni P; Moschini P; Ottobrelli A; Amoroso A; Rizzetto M; Salizzoni M; Saracco GM; Romagnoli R
Liver Int; 2017 Jan; 37(1):62-70. PubMed ID: 27344058
[TBL] [Abstract][Full Text] [Related]
18. HCV in liver transplantation.
Germani G; Tsochatzis E; Papastergiou V; Burroughs AK
Semin Immunopathol; 2013 Jan; 35(1):101-10. PubMed ID: 22829333
[TBL] [Abstract][Full Text] [Related]
19. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report.
Trakroo S; Qureshi K
Transplant Proc; 2015 Sep; 47(7):2295-7. PubMed ID: 26361703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
